Highland Capital Management (Texas)’s Neurogene NGNE Stock Holding History

Highland Capital Management (Texas)’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-7,850	Closed	-$1.09M	–	310
2015 Q2	$1.09M	Hold	7,850	–	–	0.02%	213
2015 Q1	$1.35M	Hold	7,850	–	–	0.03%	192
2014 Q4	$1.18M	Sell	7,850 -962	-11%	-$137K	0.04%	155
2014 Q3	$1.17M	Hold	8,812	–	–	0.04%	165
2014 Q2	$1.65M	Sell	8,812 -4,502	-34%	-$869K	0.06%	146
2014 Q1	$3.39M	Buy	+13,314	New	+$3.42M	0.14%	109

Other funds holding NGNE

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Highland Capital Management (Texas)'s NGNE Position: Q3 2015 in Review

Highland Capital Management (Texas) sold out of Neurogene (NGNE) in Q3 2015, closing a stake of 7,850 shares — an estimated $1.09M sold.

Highland Capital Management (Texas) first reported a position in NGNE in Q1 2014 and held it in 6 quarters. The position peaked at $3.39M in Q1 2014. 33 funds tracked by Wall St. Rank hold NGNE as of Q3 2015.

Highland Capital Management (Texas) reported no remaining Neurogene position as of Q3 2015 after selling out during the quarter.
Highland Capital Management (Texas) sold 7,850 Neurogene shares in Q3 2015, an estimated $1.09M.
Highland Capital Management (Texas) first reported a position in Neurogene in Q1 2014 and held it in 6 quarters.
Highland Capital Management (Texas)'s Neurogene position peaked at $3.39M in Q1 2014.
33 funds tracked by Wall St. Rank held Neurogene as of Q3 2015.

Based on Highland Capital Management (Texas)'s 13F filing for Q3 2015, filed 16 Nov 2015.